Story perspectives

UCB Invests $2 Billion in Georgia Biologics Facility, Creating 330 Jobs

3/25/2026

Summary

Story summary

UCB, a Belgian pharmaceutical company, announced a $2 billion investment to build its first U.S. biologics manufacturing facility in Gwinnett County, Georgia.
The plant will create 330 jobs and generate a $5 billion economic impact.
UCB Chief Executive Officer Jean-Christophe Tellier emphasized the company's commitment to long-term growth in the United States.
The facility will be part of the Rowen innovation district to foster collaboration and attract corporate investment.

1 of 1

Story summary

UCB, a Belgian pharmaceutical company, announced a $2 billion investment to build its first U.S. biologics manufacturing facility in Gwinnett County, Georgia.
The plant will create 330 jobs and generate a $5 billion economic impact.
UCB Chief Executive Officer Jean-Christophe Tellier emphasized the company's commitment to long-term growth in the United States.
The facility will be part of the Rowen innovation district to foster collaboration and attract corporate investment.